Johnson & Johnson: Beyond the Rotation Strategy
Johnson & Johnson (JNJ) shares are navigating a period of volatility as investors weigh the company’s pharmaceutical growth against broader market rotations and macroeconomic pressures. According to FactSet, the healthcare giant faces a critical test during its second-quarter earnings report, with analysts closely monitoring the performance of key oncology and immunology drugs to justify the … Read more
